[
  {
    "ts": null,
    "headline": "Prediction: These 2 Stocks Will Beat the Market in the Next Decade",
    "summary": "Eli Lilly and DexCom have been market-beaters over the past decade.  Eli Lilly could ride the wave of a strong lineup and deep pipeline, especially in weight management.  DexCom's devices are valuable to diabetes patients, but there's still a significant untapped opportunity.",
    "url": "https://finnhub.io/api/news?id=f5d89a50096f9abd7606e6f598cc8b8f99b7eed12ea63bad23c6c7bea471ab5f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748331960,
      "headline": "Prediction: These 2 Stocks Will Beat the Market in the Next Decade",
      "id": 134715841,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "Eli Lilly and DexCom have been market-beaters over the past decade.  Eli Lilly could ride the wave of a strong lineup and deep pipeline, especially in weight management.  DexCom's devices are valuable to diabetes patients, but there's still a significant untapped opportunity.",
      "url": "https://finnhub.io/api/news?id=f5d89a50096f9abd7606e6f598cc8b8f99b7eed12ea63bad23c6c7bea471ab5f"
    }
  }
]